The Board of Directors of Beacon Pharmaceuticals Ltd. has recommended 16% cash dividend for the year ended on June 30, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
184 BDT | +1.60% | -3.11% | -24.90% |
1st Jan change | Capi. | |
---|---|---|
-24.90% | 387M | |
+19.98% | 43.67B | |
+20.67% | 22.51B | |
+14.56% | 14.6B | |
+14.32% | 13.74B | |
+44.72% | 11.91B | |
-8.37% | 7.04B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+11.90% | 5.42B |
- Stock Market
- Equities
- BEACONPHAR Stock
- News Beacon Pharmaceuticals PLC
- Beacon Pharmaceuticals Ltd. Recommends Cash Dividend for the Year Ended on June 30, 2022